SCHEMBL9664722

SCHEMBL9664722

CCCCCCCCCCCCCC(=O)NCC(N)=O

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FAAH O00519 9/20 0.64
HSP90AA1 P07900 1/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
TP53 P04637 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C19 P33261 1/20 0.55
SOAT1 P35610 1/20 0.55
DNM1 Q05193 2/20 0.53
SLC6A5 Q9Y345 2/20 0.53
CASP2 P42575 1/20 0.52
GAA P10253 1/20 0.52
EPHX2 P34913 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200631 1.00 FAAH (0.64) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL7520244 1.00 FAAH (0.64) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL29060568 1.00 FAAH (0.64) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL9664822 1.00 FAAH (0.64) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL9664810 1.00 FAAH (0.64) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL7345186 0.98 FAAH (0.61) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL23974151 0.96 FAAH (0.60) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL3047227 0.96 FAAH (0.60) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL23718538 0.96 FAAH (0.60) FAAHHSP90AA1MEN1KMT2ATP53
SCHEMBL21065315 0.94 FAAH (0.57) FAAHHSP90AA1MEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP claimed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO claimed
US-20210230466-A1 PRODUCTS AND METHODS FOR THE TREATMENT OF MIXTURES OF WATER AND HYDROPHOBIC LIQUIDS B.C. RESEARCH INC. (CA) 2021-07-29 US disclosed
WO-2019232629-A1 PRODUCTS AND METHODS FOR THE TREATMENT OF MIXTURES OF WATER AND HYDROPHOBIC LIQUIDS B.C. RESEARCH INC. (CA) 2019-12-12 WO disclosed
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP disclosed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230466-A1 PRODUCTS AND METHODS FOR THE TREATMENT OF MIXTURES OF WATER AND HYDROPHOBIC LIQUIDS SLC43A1, FABP2, FABP1 FAAH 148/4885HSP90AA1 271/4885MEN1 4306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.